Dong-A, Daewoong increase market share

Published: 2011-05-26 06:59:00

Updated: 2011-05-26 06:59:00

Dong-A Pharmaceutical and Daewoong Pharmaceutical have enjoyed the brisk sales of their flagship products, according to Yakup.com., an information provider.

Yakup.com said that Daewoong’s five products exceeded 10 billion won each in the first quarter and Dong-A had four products with revenue ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK